Alyeska Investment Group’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-82,467
Closed -$5.18M 580
2022
Q1
$5.18M Buy
+82,467
New +$5.18M 0.06% 283